Previous Close | $21.08 |
Intrinsic Value | $3.51 |
Upside potential | -83% |
Data is not available at this time.
Premier, Inc. operates as a healthcare improvement company, leveraging data-driven insights and collaborative networks to enhance clinical and financial outcomes for providers, suppliers, and patients. The company generates revenue primarily through group purchasing organization (GPO) services, supply chain solutions, and performance improvement technologies. Its GPO model aggregates purchasing power for healthcare providers, securing cost efficiencies, while its SaaS-based analytics platforms support operational and clinical decision-making. Premier holds a strong position in the U.S. healthcare services sector, serving over 4,400 hospitals and health systems. Its diversified offerings, including consulting and enterprise analytics, differentiate it from pure-play GPOs, reinforcing its role as an integrated healthcare solutions provider. The company benefits from long-term contracts and recurring revenue streams, underpinning stable cash flows. However, it faces competition from larger healthcare services firms and evolving regulatory pressures in the cost-conscious healthcare landscape.
Premier reported revenue of $1.35 billion for FY 2024, with net income of $119.5 million, reflecting an 8.9% net margin. Diluted EPS stood at $1.04, while operating cash flow reached $296.6 million, demonstrating solid cash conversion. Capital expenditures of $81.2 million suggest moderate reinvestment needs, with free cash flow supporting shareholder returns and debt management. The company’s asset-light model contributes to steady profitability despite sector-wide margin pressures.
The company’s earnings power is anchored in its high-margin GPO and SaaS segments, which benefit from scalable operations. Return on invested capital (ROIC) remains healthy, supported by low capital intensity and recurring revenue streams. Premier’s ability to monetize data and analytics further enhances capital efficiency, though growth in these areas requires ongoing R&D and sales investments to maintain competitive differentiation.
Premier maintains a conservative balance sheet, with $125.1 million in cash and equivalents against $113.7 million in total debt, indicating a net cash position. The low leverage ratio provides flexibility for strategic investments or M&A. Working capital management appears efficient, with operating cash flow comfortably covering dividend obligations and modest capex requirements.
Revenue growth has been steady, driven by expansion in high-margin performance services and GPO retention. The company pays a $0.84 annual dividend per share, yielding approximately 3.4%, reflecting a commitment to returning capital. Dividend coverage is robust, with a payout ratio near 80% of net income, though reinvestment in growth initiatives may temper future increases.
Trading at a forward P/E of ~15x, Premier is valued in line with healthcare services peers, reflecting its stable cash flows and moderate growth profile. Market expectations appear balanced, pricing in incremental gains from analytics adoption but limited upside from core GPO maturation. The stock’s yield may appeal to income-oriented investors amid sector volatility.
Premier’s integrated model and data capabilities position it to capitalize on healthcare’s shift toward value-based care. Near-term headwinds include GPO contract renewals and supplier pricing pressures, but long-term opportunities lie in analytics adoption and cross-selling. Management’s focus on margin expansion and tuck-in acquisitions could drive outperformance if execution risks are mitigated.
10-K filing, company investor relations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |